59 related articles for article (PubMed ID: 24780487)
1. Glucarpidase for the management of elevated methotrexate levels in patients with impaired renal function.
Fermiano M; Bergsbaken J; Kolesar JM
Am J Health Syst Pharm; 2014 May; 71(10):793-8. PubMed ID: 24780487
[TBL] [Abstract][Full Text] [Related]
2. The use of glucarpidase as a rescue therapy for high dose methotrexate toxicity - a review of pharmacological and clinical data.
Kielbowski K; Rosik J; Bakinowska E; Gromowska E; Ustianowski Ł; Szostak B; Pawlik A
Expert Opin Drug Metab Toxicol; 2023; 19(11):741-750. PubMed ID: 37846862
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate level discrepancy post-glucarpidase: A pediatric case series and review of literature.
Kibby D; Trinkman H
Pediatr Blood Cancer; 2024 Mar; 71(3):e30831. PubMed ID: 38149827
[TBL] [Abstract][Full Text] [Related]
4. A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Janeway KA; Gros L; Schwartz S; Daugherty C; Gallardo E; Hill C; Thomas E; Ward S; Rizzari C
Pediatr Blood Cancer; 2023 Jun; ():e30506. PubMed ID: 37369988
[TBL] [Abstract][Full Text] [Related]
5. Use of glucarpidase (carboxypeptidase-G2) in pediatric cancer patients: 11-year experience of a tertiary center.
Vila R; Rubio-San-Simón A; Zubiaur P; Navares-Gómez M; Gómez-Hernández P; Arce B; Madero L
EJHaem; 2023 Nov; 4(4):1052-1058. PubMed ID: 38024601
[TBL] [Abstract][Full Text] [Related]
6. Rescue Therapies for AKI in Onconephrology: Rasburicase and Glucarpidase.
Latcha S; Shah CV
Semin Nephrol; 2022 Nov; 42(6):151342. PubMed ID: 37167817
[TBL] [Abstract][Full Text] [Related]
7. Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Meyers PA
Pediatr Blood Cancer; 2023 Nov; 70(11):e30617. PubMed ID: 37553477
[No Abstract] [Full Text] [Related]
8. Late administration of glucarpidase in methotrexate intoxication: Do we have more time than we thought?
Miceli G; Daidone M; Corpora F; Gaudio FD; Tuttolomondo A;
Eur J Intern Med; 2024 Jan; 119():144-145. PubMed ID: 37806838
[No Abstract] [Full Text] [Related]
9. Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.
Ogawa A; Kawamoto H; Hara J; Kikuta A; Ogawa C; Hiraga H; Yoshimura K; Miyairi K; Omori R; Ro T; Kamei Y; Kimura T
Cancer Chemother Pharmacol; 2024 Mar; ():. PubMed ID: 38478074
[TBL] [Abstract][Full Text] [Related]
10. Early intervention is important when administering glucarpidase for methotrexate intoxication.
Bettini LR; Rizzari C
Eur J Intern Med; 2024 Feb; 120():118-119. PubMed ID: 38102037
[No Abstract] [Full Text] [Related]
11. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma.
Truong HL; Barreto JN; Mara KC; Hampel PJ; Micallef IN; Nowakowski GS; Thanarajasingam G; Thompson CA; Wang Y; Witzig TE; Herrmann SM; Leung N
JCO Oncol Pract; 2024 Feb; ():OP2300628. PubMed ID: 38408299
[TBL] [Abstract][Full Text] [Related]
12. High-Dose Methotrexate: Nursing Considerations for Administration and Supportive Care.
Roche B; Clarke PA; Ford D; Collins Shaver S; Thompson J
Clin J Oncol Nurs; 2023 Jan; 27(1):47-54. PubMed ID: 37677820
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidote.
Sharma A; Benoit P; Lansigan F; Nierenberg D
Front Oncol; 2023; 13():1237178. PubMed ID: 37941559
[TBL] [Abstract][Full Text] [Related]
14. Reply to: Comment on: A pooled subgroup analysis of glucarpidase treatment in 86 pediatric, adolescent, and young adult patients receiving high-dose methotrexate therapy in open-label trials.
Janeway KA; Gros L; Schwartz S; Daugherty C; Gallardo E; Hill C; Thomas E; Ward S; Rizzari C
Pediatr Blood Cancer; 2023 Dec; 70(12):e30662. PubMed ID: 37795968
[No Abstract] [Full Text] [Related]
15. Early intervention is important when administering glucarpidase for methotrexate intoxication. Author's reply.
Miceli G; Daidone M; Corpora F; Di Gaudio F; Tuttolomondo A;
Eur J Intern Med; 2024 Apr; ():. PubMed ID: 38685140
[No Abstract] [Full Text] [Related]
16. Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase.
Connors NJ; Sise ME; Nelson LS; Hoffman RS; Smith SW
Clin Kidney J; 2014 Dec; 7(6):590-2. PubMed ID: 25859377
[TBL] [Abstract][Full Text] [Related]
17. Preventing and Managing Toxicities of High-Dose Methotrexate.
Howard SC; McCormick J; Pui CH; Buddington RK; Harvey RD
Oncologist; 2016 Dec; 21(12):1471-1482. PubMed ID: 27496039
[TBL] [Abstract][Full Text] [Related]
18. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR
Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103
[TBL] [Abstract][Full Text] [Related]
19. Practical considerations for the administration of glucarpidase in high-dose methotrexate (HDMTX) induced renal dysfunction.
Widemann BC
Pediatr Blood Cancer; 2015 Sep; 62(9):1512-3. PubMed ID: 25940351
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
